AUG 8, 2026 · JOURNAL ARTICLE
“Molecular divergence shapes lung- and liver-preferential metastasis in HER2-positive breast cancer”
npj Breast Cancer
A mechanistic study establishing novel murine models of organ-preferential metastasis with supporting transcriptomic validation in clinical cohorts, but lacking clinical trial evidence of therapeutic efficacy.
Reported
Hepatic penetrance95%
Time to achieve hepatic penetrance10 weeks